Steroid resistance in asthma: mechanisms and treatment options (Q37140072)

18 August 2017

1 reference

title

Steroid resistance in asthma: mechanisms and treatment options (English)

1 reference

18 August 2017

0 references

Ian M Adcock

1

0 references

Kian Fan Chung

object named as

Kian Fan Chung

series ordinal

5

0 references

Pankaj K Bhavsar

series ordinal

3

object named as

Pank Bhavsar

1 reference

18 August 2017

2

Paul A Ford

1 reference

18 August 2017

Tehireem Ahmad

4

1 reference

18 August 2017

1 April 2008

1 reference

Current Allergy and Asthma Reports

18 August 2017

1 reference

18 August 2017

8

1 reference

18 August 2017

2

1 reference

18 August 2017

171-178

1 reference

https://scigraph.springernature.com/pub.10.1007/s11882-008-0028-4

18 August 2017

0 references

cites work

Clinical control and histopathologic outcome of asthma when using airway hyperresponsiveness as an additional guide to long-term treatment. The AMPUL Study Group

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11882-008-0028-4

Steroid Resistance in Bronchial Asthma

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11882-008-0028-4

Methotrexate regulates the expression of glucocorticoid receptor alpha and beta isoforms in normal human peripheral mononuclear cells and human lymphocyte cell lines in vitro

21 January 2018

1 reference

12 December 2020

Oxidative stress and redox regulation of lung inflammation in COPD.

1 reference

12 December 2020

Epithelial cell proliferation contributes to airway remodeling in severe asthma

1 reference

12 December 2020

Reversing the defective induction of IL-10-secreting regulatory T cells in glucocorticoid-resistant asthma patients

1 reference

12 December 2020

Relative corticosteroid insensitivity of peripheral blood mononuclear cells in severe asthma

1 reference

12 December 2020

Steroid receptor phosphorylation: a key modulator of multiple receptor functions

1 reference

12 December 2020

Failure of montelukast to reduce sputum eosinophilia in high-dose corticosteroid-dependent asthma

1 reference

12 December 2020

Evidence of a role of tumor necrosis factor alpha in refractory asthma

1 reference

12 December 2020

Antiinflammatory effects of dexamethasone are partly dependent on induction of dual specificity phosphatase 1.

1 reference

12 December 2020

Expression of nonmuscle cofilin-1 and steroid responsiveness in severe asthma

1 reference

12 December 2020

Histone deacetylase 2-mediated deacetylation of the glucocorticoid receptor enables NF-kappaB suppression

1 reference

12 December 2020

Risk factors of frequent exacerbations in difficult-to-treat asthma

1 reference

12 December 2020

Genetic admixture and asthma-related phenotypes in Mexican American and Puerto Rican asthmatics

1 reference

12 December 2020

Severe asthma in adults: what are the important questions?

1 reference

12 December 2020

Making sense of asthma genes

1 reference

12 December 2020

Corticosteroid resistance in chronic asthma

1 reference

12 December 2020

Regional lung deposition and bronchodilator response as a function of beta2-agonist particle size

1 reference

12 December 2020

Cost-effectiveness of omalizumab in adults with severe asthma: results from the Asthma Policy Model

1 reference

12 December 2020

Airway remodeling and lack of bronchodilator response in steroid-resistant asthma

1 reference

12 December 2020

Exhaled nitric oxide identifies the persistent eosinophilic phenotype in severe refractory asthma.

1 reference

12 December 2020

Altered protein tyrosine phosphorylation in asthmatic bronchial epithelium

1 reference

12 December 2020

Increased expression of ADAM33 and ADAM8 with disease progression in asthma

1 reference

12 December 2020

Bronchial mucosal inflammation and upregulation of CXC chemoattractants and receptors in severe exacerbations of asthma

1 reference

12 December 2020

An electronic nose in the discrimination of patients with asthma and controls

1 reference

12 December 2020

Systemic glucocorticoid reduces bronchial mucosal activation of activator protein 1 components in glucocorticoid-sensitive but not glucocorticoid-resistant asthmatic patients

1 reference

12 December 2020

SOCS-3 regulates onset and maintenance of T(H)2-mediated allergic responses.

1 reference

12 December 2020

Effects of corticosteroids on noninvasive biomarkers of inflammation in asthma and chronic obstructive pulmonary disease

1 reference

12 December 2020

Role of Brg1 and HDAC2 in GR trans-repression of the pituitary POMC gene and misexpression in Cushing disease.

1 reference

12 December 2020

Kinase inhibitors and airway inflammation.

1 reference

12 December 2020

Effects of smoking cessation on lung function and airway inflammation in smokers with asthma.

1 reference

12 December 2020

Tumour necrosis factor (TNFalpha) as a novel therapeutic target in symptomatic corticosteroid dependent asthma

1 reference

12 December 2020

1 reference

12 December 2020

A rational approach to the management of severe refractory asthma

1 reference

12 December 2020

Correlation of systemic superoxide dismutase deficiency to airflow obstruction in asthma

1 reference

12 December 2020

Lipoxin A4 levels in asthma: relation with disease severity and aspirin sensitivity

1 reference

12 December 2020

Cytokine and anti-cytokine therapy for asthma

1 reference

12 December 2020

Increased glucocorticoid receptor beta alters steroid response in glucocorticoid-insensitive asthma

1 reference

12 December 2020

Nuclear receptors and chromatin remodeling machinery

1 reference

12 December 2020

Comparison of twice-daily inhaled ciclesonide and fluticasone propionate in patients with moderate-to-severe persistent asthma

1 reference

12 December 2020

Severe asthma: lessons from the Severe Asthma Research Program

1 reference

12 December 2020

Specificity of basement membrane thickening in severe asthma

1 reference

12 December 2020

Safety and efficacy of bronchial thermoplasty in symptomatic, severe asthma

1 reference

12 December 2020

IL4R alpha mutations are associated with asthma exacerbations and mast cell/IgE expression

1 reference

12 December 2020

Characterization of the severe asthma phenotype by the National Heart, Lung, and Blood Institute's Severe Asthma Research Program

1 reference

12 December 2020

Update on glucocorticoid action and resistance

1 reference

12 December 2020

Glucocorticoid receptor alpha:beta ratio in blood mononuclear cells is reduced in cigarette smokers

1 reference

12 December 2020

Corticosteroid-insensitive asthma: molecular mechanisms.

1 reference

12 December 2020

Profiling of genes expressed in peripheral blood mononuclear cells predicts glucocorticoid sensitivity in asthma patients

1 reference

12 December 2020

Ciclesonide, a novel inhaled steroid, does not affect hypothalamic-pituitary-adrenal axis function in patients with moderate-to-severe persistent asthma

1 reference

12 December 2020

Cytoskeletal and cell contact control of the glucocorticoid pathway

1 reference

12 December 2020

Human glucocorticoid receptor beta binds RU-486 and is transcriptionally active.

1 reference

12 December 2020

Clarithromycin targets neutrophilic airway inflammation in refractory asthma.

1 reference

12 December 2020

Association of control and risk of severe asthma-related events in severe or difficult-to-treat asthma patients

1 reference

12 December 2020

Blood neutrophil activation markers in severe asthma: lack of inhibition by prednisolone therapy

1 reference

12 December 2020

Asthma control during the year after bronchial thermoplasty.

1 reference

12 December 2020

10.1007/S11882-008-0028-4

Identifiers

DOI

1 reference

release_4euv5ca73fhrnf7wijtbrev6x4

18 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/4euv5ca73fhrnf7wijtbrev6x4

24 November 2022

mapped directly with Wikidata item

PubMed ID

18417060

1 reference

PubMed ID

18417060